AllianceBernstein’s NeoGenomics NEO Stock Holding History

AllianceBernstein’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Hold	160,340	–	–	﹤0.01%	2311
2026 Q1	$1.89M	Buy	160,340 +4,086	+3%	+$43K	﹤0.01%	2039
2025 Q4	$1.84M	Sell	156,254 -4,086	-3%	-$44.1K	﹤0.01%	2044
2025 Q3	$1.24M	Hold	160,340	–	–	﹤0.01%	2248
2025 Q2	$1.17M	Hold	160,340	–	–	﹤0.01%	2207
2025 Q1	$1.52M	Hold	160,340	–	–	﹤0.01%	2042
2024 Q4	$2.64M	Sell	160,340 -10,157	-6%	-$158K	﹤0.01%	1819
2024 Q3	$2.51M	Hold	170,497	–	–	﹤0.01%	1843
2024 Q2	$2.36M	Hold	170,497	–	–	﹤0.01%	1848
2024 Q1	$2.68M	Hold	170,497	–	–	﹤0.01%	1764
2023 Q4	$2.76M	Buy	170,497 +1,800	+1%	+$29.5K	﹤0.01%	1766
2023 Q3	$2.07M	Sell	168,697 -55,720	-25%	-$829K	﹤0.01%	1855
2023 Q2	$3.61M	Buy	224,417 +22,340	+11%	+$368K	﹤0.01%	1571
2023 Q1	$3.52M	Sell	202,077 -32,660	-14%	-$465K	﹤0.01%	1548
2022 Q4	$2.17M	Sell	234,737 -53,195	-18%	-$496K	﹤0.01%	1864
2022 Q3	$2.48M	Buy	287,932 +65,315	+29%	+$649K	﹤0.01%	1747
2022 Q2	$1.81M	Buy	222,617 +2,361	+1%	+$22.5K	﹤0.01%	2010
2022 Q1	$2.68M	Sell	220,256 -33,490	-13%	-$705K	﹤0.01%	1916
2021 Q4	$8.66M	Buy	253,746 +35,188	+16%	+$1.38M	﹤0.01%	1322
2021 Q3	$10.5M	Sell	218,558 -13,410	-6%	-$621K	﹤0.01%	1209
2021 Q2	$10.5M	Buy	231,968 +10,157	+5%	+$450K	﹤0.01%	1216
2021 Q1	$10.7M	Sell	221,811 -6,480	-3%	-$337K	﹤0.01%	1168
2020 Q4	$12.3M	Buy	228,291 +45,791	+25%	+$2.07M	0.01%	1034
2020 Q3	$6.73M	Sell	182,500 -3,170	-2%	-$118K	﹤0.01%	1190
2020 Q2	$5.75M	Buy	185,670 +29,820	+19%	+$826K	﹤0.01%	1252
2020 Q1	$4.3M	Buy	155,850 +9,850	+7%	+$295K	﹤0.01%	1258
2019 Q4	$4.27M	Buy	146,000 +17,650	+14%	+$420K	﹤0.01%	1521
2019 Q3	$2.45M	Sell	128,350 -21,050	-14%	-$494K	﹤0.01%	1808
2019 Q2	$3.28M	Buy	149,400 +75,100	+101%	+$1.65M	﹤0.01%	1681
2019 Q1	$1.52M	Buy	74,300 +2,800	+4%	+$48.7K	﹤0.01%	2058
2018 Q4	$902K	Buy	71,500 +1,000	+1%	+$14.9K	﹤0.01%	2240
2018 Q3	$1.08M	Hold	70,500	–	–	﹤0.01%	2295
2018 Q2	$924K	Buy	70,500 +2,900	+4%	+$31.9K	﹤0.01%	2352
2018 Q1	$552K	Buy	67,600 +4,900	+8%	+$39.7K	﹤0.01%	2498
2017 Q4	$556K	Buy	62,700 +17,200	+38%	+$159K	﹤0.01%	2498
2017 Q3	$506K	Hold	45,500	–	–	﹤0.01%	2569
2017 Q2	$408K	Buy	45,500 +11,700	+35%	+$92.9K	﹤0.01%	2684
2017 Q1	$267K	Hold	33,800	–	–	﹤0.01%	2757
2016 Q4	$290K	Hold	33,800	–	–	﹤0.01%	2759
2016 Q3	$278K	Buy	33,800 +4,700	+16%	+$39.4K	﹤0.01%	2725
2016 Q2	$234K	Buy	+29,100	New	+$233K	﹤0.01%	2767
2013 Q4	–	Sell	-2,000	Closed	-$6K	–	3467
2013 Q3	$6K	Sell	2,000 -886	-31%	-$2.5K	﹤0.01%	3191
2013 Q2	$11K	Buy	+2,886	New	+$11K	﹤0.01%	3126

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

AllianceBernstein's NEO Position: Q2 2026 in Review

AllianceBernstein held its NeoGenomics (NEO) position steady in Q2 2026 at 160,340 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2311.

AllianceBernstein first reported a position in NEO in Q2 2013 and has held it in 43 quarters since. The position peaked at $12.3M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

AllianceBernstein held 160,340 shares of NeoGenomics worth $1.19M as of Q2 2026.
AllianceBernstein left its NeoGenomics share count unchanged in Q2 2026.
NeoGenomics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2311 holding.
AllianceBernstein first reported a position in NeoGenomics in Q2 2013 and has held it in 43 quarters since.
AllianceBernstein's NeoGenomics position peaked at $12.3M in Q4 2020.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.